Xencor, Inc Number of Operating Segments
Xencor, Inc (XNCR) reported Number of Operating Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2026-08-05
- Xencor, Inc number of operating segments for the quarter ending 2014-03-31 was 1.00 item.
item
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month |
|---|---|---|
| 2014-06-30 | 1.00 item 10-Q · filed 2014-08-01 | |
| 2014-03-31 | 1.00 item 10-Q · filed 2014-05-15 |
segment
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 12 month |
|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-08-05 | ||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-02-25 | ||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-02-27 | ||
| 2023-12-31 | 1.00 segment 10-K/A · filed 2025-02-24 | ||
| 2022-12-31 | 1.00 segment 10-K · filed 2023-02-27 | ||
| 2021-12-31 | 1.00 segment 10-K · filed 2022-02-24 | ||
| 2020-12-31 | 1.00 segment 10-K · filed 2021-02-24 | ||
| 2019-12-31 | 1.00 segment 10-K · filed 2020-02-25 | ||
| 2018-12-31 | 1.00 segment 10-K · filed 2019-02-26 | ||
| 2017-12-31 | 1.00 segment 10-K · filed 2018-02-28 | ||
| 2016-12-31 | 1.00 segment 10-K · filed 2017-03-01 | ||
| 2015-12-31 | 1.00 segment 10-K · filed 2016-03-08 | ||
| 2014-12-31 | 1.00 segment 10-K · filed 2015-02-23 | ||
| 2014-09-30 | 1.00 segment 10-Q · filed 2014-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |